Skip to main content Skip to navigation

Phage-based Technologies Against AMR Conference

n

This conference took place on 15-16 September 2016. Relive the higlights here.

The focus of this conference is to encourage new interdisciplinary approaches based on phages and plasmids that could be used to fight Antimicrobial Resistance (AMR).

The conference was co-organised by EVOPROG and INTEGRATE AMR. EVOPROG is an EU FET-Proactive consortium devoted to developing new technology to engineer molecules based on bacteriophages (phages), continuous cultures and evolution. EVOPROG exemplifies the usefulness of novel technologies and approaches to engineer phages, which could transform phage therapy as we know it today.

The conference facilitated discussions between specialists who have expertise in phages, virology, directed evolution, microbiology & microbial diversity and encourage collaborations to tackle AMR.

Our goal was to provide an innovative interface for directed evolutionary technologies and antimicrobial resistance, to foster learning, inspiration and wonder – and provoke conversations that matter.

In the age of genome sequencing and engineering, new emerging technologies can be used to design novel antimicrobial strategies:

1) Enhance existing antibiotics.

2) Alternative antimicrobials such as molecules derived from phages.

3) Synthetic phages or phage-like particles as antimicrobials.

Speakers

Ian Molineux, University of Texas at Austin
Victor de Lorenzo, CSICLink opens in a new window

Stephen Abedon, Ohio State University Link opens in a new window
Udi Qimron, Tel Aviv UniversityLink opens in a new window
Mark Isalan, Imperial College LondonLink opens in a new window
Jim Haseloff, Cambridge UniversityLink opens in a new window
Didier Mazel, Institute PasteurLink opens in a new window
Fernando de la Cruz, Universidad de CantabriaLink opens in a new window
Alfonso Rodriguez-Paton, Universidad Politecnica de MadridLink opens in a new window
George Salmond, University of CambridgeLink opens in a new window
Martha Clokie, University of LeicesterLink opens in a new window

David Harper, Evolution BiotechnologiesLink opens in a new window

Andrzej Gorski, Polish Academy of SciencesLink opens in a new window

Mark van Raaij, Madrid CNBLink opens in a new window


Alfonso Jaramillo, University of WarwickLink opens in a new window

Ramesh Wigneshweraraj, Imperial College LondonLink opens in a new window

Antonia Sagona, University of WarwickLink opens in a new window

Meera Unnikrishnan, University of WarwickLink opens in a new window

Akos Nyerges, Hungarian Academy of SciencesLink opens in a new window

Freya Harrison, University of WarwickLink opens in a new window

Stratford-upon-Avon

Conference chair:

Prof. Alfonso JaramilloLink opens in a new window, Professor of Synthetic Biology

Coordinator of the EVOPROG consortium

Organised and funded by:

EVOPROG consortium

INTEGRATE AMRLink opens in a new window, 'Integrating expertise across disciplines to tackle antimicrobial resistance'

Venue: Royal Shakespeare Company. The Other Place, RSC, Stratford-upon-AvonLink opens in a new window
Dates: 15 & 16 Sep 2016

Start: 13:00 15 Sep (Lunch)